Evidence map›Paper›PMID 27082824›Full record

ArticleJournal of aerosol medicine and pulmonary drug delivery2016

Validating Whole-Airway CFD Predictions of DPI Aerosol Deposition at Multiple Flow Rates.

P Worth Longest, Geng Tian, Navvab Khajeh-Hosseini-Dalasm, Michael Hindle

Abstract readComparative StudyValidation Study
In one paragraph

Article in Journal of aerosol medicine and pulmonary drug delivery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 92 citations in OpenAlex.

  1. Direct Numerical Simulations of Inhalation in a 23-Generation Lung Model.International journal for numerical methods in biomedical engineering · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. [Numerical simulation on the deposition characteristics of inhaled particles in human pulmonary acinus region under the influence of multi-factors].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2020
    Article
  16. A Review of Respiratory Anatomical Development, Air Flow Characterization and Particle Deposition.International journal of environmental research and public health · 2020
    Review
  17. Patient-specific modeling of aerosol delivery in healthy and asthmatic adults.Journal of applied physiology (Bethesda, Md. : 1985) · 2019
    Article
  18. Devices for Improved Delivery of Nebulized Pharmaceutical Aerosols to the Lungs.Journal of aerosol medicine and pulmonary drug delivery · 2019
    Review
  19. MultiscaleCurrent opinion in biomedical engineering · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

P Worth Longest1 Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University , Richmond, Virginia.
Geng Tian1 Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University , Richmond, Virginia.
Navvab Khajeh-Hosseini-Dalasm1 Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University , Richmond, Virginia.
Michael Hindle2 Department of Pharmaceutics, Virginia Commonwealth University , Richmond, Virginia.
Virginia Commonwealth University · US

Funding

High Efficiency Aerosol Delivery using the Excipient Enhanced Growth Concept: A Human Proof of Concept StudyR01HL107333 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI HINDLE, MICHAEL, LONGEST, P. WORTH · 2011 to 2020
$4.2M
Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled DrugU01FD004570 · FDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI LONGEST, P. WORTH · 2012 to 2014
$347k
FDA HHS U01 FD004570NHLBI NIH HHS R01 HL107333
6 · The paper itself

Abstract

backgroundThe objective of this study was to compare aerosol deposition predictions of a new whole-airway CFD model with available in vivo data for a dry powder inhaler (DPI) considered across multiple inhalation waveforms, which affect both the particle size distribution (PSD) and particle deposition.

methodsThe Novolizer DPI with a budesonide formulation was selected based on the availability of 2D gamma scintigraphy data in humans for three different well-defined inhalation waveforms. Initial in vitro cascade impaction experiments were conducted at multiple constant (square-wave) particle sizing flow rates to characterize PSDs. The whole-airway CFD modeling approach implemented the experimentally determined PSDs at the point of aerosol formation in the inhaler. Complete characteristic airway geometries for an adult were evaluated through the lobar bronchi, followed by stochastic individual pathway (SIP) approximations through the tracheobronchial region and new acinar moving wall models of the alveolar region.

resultsIt was determined that the PSD used for each inhalation waveform should be based on a constant particle sizing flow rate equal to the average of the inhalation waveform's peak inspiratory flow rate (PIFR) and mean flow rate [i.e., AVG(PIFR, Mean)]. Using this technique, agreement with the in vivo data was acceptable with <15% relative differences averaged across the three regions considered for all inhalation waveforms. Defining a peripheral to central deposition ratio (P/C) based on alveolar and tracheobronchial compartments, respectively, large flow-rate-dependent differences were observed, which were not evident in the original 2D in vivo data.

conclusionsThe agreement between the CFD predictions and in vivo data was dependent on accurate initial estimates of the PSD, emphasizing the need for a combination in vitro-in silico approach. Furthermore, use of the AVG(PIFR, Mean) value was identified as a potentially useful method for characterizing a DPI aerosol at a constant flow rate.

Indexed as

Computer SimulationDry Powder InhalersModels, AnatomicAdministration, InhalationAdultAerosolsBronchodilator AgentsBudesonideDrug CompoundingGlucocorticoidsHumansParticle SizeReproducibility of ResultsRespirationRespiratory SystemStochastic ProcessesAerosolsBronchodilator AgentsBudesonideGlucocorticoidscomputational fluid dynamics (CFD)pharmaceutical aerosolspredictions of aerosol depositionrespiratory drug deliverystochastic individual pathway model

Identifiers

PMID27082824
PMCPMC5220557
OpenAlexW2337879030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.